scholarly journals Combined bilateral retinal arteriolar and retinal vein occlusion: An unusual presentation of systemic lupus erythematosus

2014 ◽  
Vol 19 (1) ◽  
pp. 40
Author(s):  
Shashank Banait ◽  
Jyoti Jain ◽  
Benjamine Khaingate ◽  
Vinod Adalkhiya
F1000Research ◽  
2021 ◽  
Vol 10 ◽  
pp. 761
Author(s):  
Marwa Ben Brahim ◽  
Sondes Arfa ◽  
Fadia Boubaker ◽  
Jihen Chelly ◽  
Wafa Ammari ◽  
...  

Systemic lupus erythematosus (SLE) is a chronic, autoimmune disease characterized by widespread clinical manifestations and immunological disorders. A myriad of ocular manifestations can be seen in patients with SLE. The most vision-threatening complication is vaso-occlusive retinopathy including retinal vein occlusion (RVO). RVO associated with SLE is well described in the literature and its association with antiphospholipid antibodies is recognized. However, RVO as the initial manifestation of SLE is scarcely reported. Herein, we report the first case of recurrent RVO as the revealing manifestation of SLE in a 40-year-old male patient. He had two consecutive episodes of decreased vision. Ophthalmologic examination disclosed a branch retinal vein occlusion the first time and a central retinal vein occlusion the second time. The diagnosis of SLE was established based on clinical and immunological criteria. He was prescribed antiplatelet therapy, hydroxychloroquine at 5.5 mg/kg/day, and intravitreal anti-vascular endothelial growth factor (VEGF) antibodies regimen. He slowly improved under treatment.


Lupus ◽  
2020 ◽  
Vol 29 (8) ◽  
pp. 987-992 ◽  
Author(s):  
Nazanin Ebrahimiadib ◽  
Hamid Riazi-Esfahani ◽  
Mostafa Heidari ◽  
Alireza Mahmoudi

In this report, we describe two patients with systemic lupus erythematosus (SLE) who manifested with posterior segment flare-up approximately three months after cessation of hydroxychloroquine (HCQ). They were stable systemically with no history of hypertension or nephropathy at the time of referral. Our first patient presented with bilateral retinal vein occlusion, while evidence of choroidal involvement such as vascular leakage and wedge-shaped filling delay was present in indocyanine green angiography of both patients. HCQ is well known to have a role in the treatment of SLE for its immunomodulatory and antithrombotic effects. Although reports of systemic flare-up of SLE following HCQ cessation exist in the literature, this is the first report of ocular flare-up in such settings.


F1000Research ◽  
2021 ◽  
Vol 10 ◽  
pp. 761
Author(s):  
Marwa Ben Brahim ◽  
Sondes Arfa ◽  
Fadia Boubaker ◽  
Jihen Chelly ◽  
Wafa Ammari ◽  
...  

Systemic lupus erythematosus (SLE) is a chronic, autoimmune disease characterized by widespread clinical manifestations and immunological disorders. A myriad of ocular manifestations can be seen in patients with SLE. The most vision-threatening complication is vaso-occlusive retinopathy including retinal vein occlusion (RVO). RVO associated with SLE is well described in the literature and its association with antiphospholipid antibodies is recognized. However, RVO as the initial manifestation of SLE is scarcely reported. Herein, we report the first case of recurrent RVO as the primary manifestation of SLE in a 40-year-old male patient. He had two consecutive episodes of decreased vision. Ophthalmologic examination disclosed a branch retinal vein occlusion the first time and a central retinal vein occlusion the second time. The diagnosis of SLE was established based on clinical and immunological criteria. He was prescribed antiplatelet therapy, hydroxychloroquine at 5.5 mg/kg/day, and intravitreal anti-vascular endothelial growth factor (VEGF) antibodies regimen. He slowly improved under treatment.


2018 ◽  
Vol 131 (5) ◽  
pp. e189-e190 ◽  
Author(s):  
Persio D. López ◽  
Rachna Valvani ◽  
Savi Mushiyev ◽  
Ferdinand Visco ◽  
Gerald Pekler

Sign in / Sign up

Export Citation Format

Share Document